Meridian Bioscience HSV 1, HSV 2 Tests Get FDA Clearance | GenomeWeb

NEW YORK (GenomeWeb) – Meridian Biosciences said today that it has received clearance from the US Food and Drug Administration for the Illumigene HSV 1&2 assays.

The assays use loop-mediated isothermal amplification to detect the DNA of herpes simplex 1 and herpes simplex 2 virus from cutaneous and mucocutaneous patient samples in less than one hour, and had previously received CE mark in May.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.